Brief: Moberg Pharma Q2 EBITDA SEK -4.3 Million
13/08/2026 07:01
BRIEF-Moberg Pharma Q2 EBITDA SEK -4.3 Million Aug 13 (Reuters) - Moberg Pharma Q2 EPS SEK -0.07.
- Q2 EBIT SEK -4.7 million
- Q2 net income SEK -3.3 million
Recent news on Moberg Pharma AB (publ)
See all newsSweden's Moberg Pharma Q2 loss narrows as revenue rises
Brief: Moberg Pharma Q2 EBITDA SEK -4.3 Million
Brief: Moberg Pharma Names Vaidrius Navikas Chief Medical Officer
Brief: Moberg Pharma And Karo Healthcare Expand Collaboration
Moberg Pharma Q1 revenue rises, losses narrow on Nordic market share gains